arrow
V

Vladimir А. Gushchin

Gamaleya National Research Centre for Epidemiology and Microbiology
H指数:27
被引数:4,374

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Structural Design of T-Cell Epitope-Based mRNA Vaccine Constructs Determines the Quality of T-Cell Immunity and Protective Efficacy Against SARS-CoV-2 in Mice

基于T细胞表位的mRNA疫苗构建体的结构设计决定了T细胞免疫的质量以及小鼠中对抗SARS-CoV-2的保护效力

2026-04-040
OAAI
Sputnik V update: safety and neutralizing antibodies in healthy adults and adolescents

卫星V疫苗更新:健康成人和青少年中的安全性与中和抗体

2026-03-270
OA
An Assessment of Regional Genetic Diversity of HIV-1

HIV-1区域遗传多样性的评估

2025-11-300
OAAI
Immunogenicity and Efficacy of Combined mRNA Vaccine Against Influenza and SARS-CoV-2 in Mice Animal Models

流感和SARS-CoV-2 mRNA联合疫苗在小鼠动物模型中的免疫原性和有效性

2024-10-241
OAAI
Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5

Sputnik V疫苗在hACE2-Transgenic小鼠中针对同源和异源SARS-CoV-2谱系 (包括远距离Omicron BA.5) 的免疫原性和保护性

2024-10-080
OAAI
Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections
2024-07-241
OAAI
Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response
2024-04-163
OAAI
Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins

基于SARS-CoV-2结构蛋白的mRNA脂质纳米粒疫苗中S-糖蛋白在提供免疫原性和保护性免疫中的主要作用

2024-04-022
OAAI
Synthesis and Antiviral Activity of Novel β-D-N4-Hydroxycytidine Ester Prodrugs as Potential Compounds for the Treatment of SARS-CoV-2 and Other Human Coronaviruses

新型 β-d-n4-羟基胞苷酯前药的合成和抗病毒活性,作为治疗SARS-CoV-2和其他人类冠状病毒的潜在化合物

2023-12-262
OAAI